Hemostatic Disorders
Showing 9951 - 9975 of >10,000
Inflammatory and Acquired Dysimmune Diseases (CARMIN)
Completed
- Inflammatory and Acquired Dysimmune Diseases
- Data collection
- (no location specified)
Jul 15, 2016
Healthy Trial in London (20 mg AZD7325, Placebo)
Completed
- Healthy
- 20 mg AZD7325
- Placebo
-
London, United KingdomNational Hospital for Neurology and Neurosurgery
Jul 26, 2016
Depression, Bipolar Disorder, Anhedonia Trial in Chicago (Behavioral Activation-Full, Behavioral Activation-Short, Bipolar
Completed
- Depression
- +2 more
- Behavioral Activation-Full
- +2 more
-
Chicago, IllinoisNorthwestern University
Sep 28, 2016
Neuromyelitis Optica Spectrum Disorders, Mycophenolate Mofetil, Efficacy and Safety Trial (Mycophenolate mofetil, Prednisone)
Unknown status
- Neuromyelitis Optica Spectrum Disorders
- +2 more
- Mycophenolate mofetil
- Prednisone
- (no location specified)
Jun 19, 2016
Second Trimester Maternal Serum Homocysteine Levels and Uterine
Completed
- Preeclampsia
- (no location specified)
Aug 1, 2016
Near Death Experience (NDE) and Migraine
Unknown status
- Migraine
- Near Death Experience
- questioning
-
Marseille, FranceAssistance Publique Hôpitaux de Marseille Hôpital de la Timone
Aug 3, 2016
Human Immunodeficiency Virus (HIV), HIV Associated Neurocognitive Disorders (HAND) Trial in Sydney, Melbourne (Raltegravir)
Terminated
- Human Immunodeficiency Virus (HIV)
- HIV Associated Neurocognitive Disorders (HAND)
-
Sydney, New South Wales, Australia
- +1 more
May 19, 2016
Multiple Sclerosis, Stroke Trial (Serious games, Exergames)
Completed
- Multiple Sclerosis
- Stroke
- Serious games
- Exergames
- (no location specified)
May 5, 2016
Intraoperative Bleeding Trial in Palo Alto, Seattle (BioFoam Surgical Matrix, Gelfoam Plus)
Terminated
- Intraoperative Bleeding
- BioFoam Surgical Matrix
- Gelfoam Plus
-
Palo Alto, California
- +1 more
Apr 29, 2015
Epilepsy, Ictal/Post-ictal Hypoxemia Trial in Lyon (fluoxetine 20 mg, 20 mg)
Completed
- Epilepsy
- Ictal/Post-ictal Hypoxemia
- fluoxetine 20 mg
- placebo 20 mg
-
Lyon, FranceService de Neurologie Fonctionnelle et d'Epileptologie, Hôpital
Oct 4, 2016
Taking Account of Inobservable Periods in Longitudinal Drug
Completed
- Drug Exposition
- Exposition to hypnotics or anxiolytics benzodiazepines
- +3 more
- (no location specified)
Sep 2, 2016
Generalised Anxiety Disorder Trial in London (Sertraline, Cognitive Behavioural Therapy)
Terminated
- Generalised Anxiety Disorder
- Sertraline
- Cognitive Behavioural Therapy
-
London, United KingdomCamden & Islington (with Kingston)
Jul 8, 2016
Schizophrenia, Schizoaffective Disorder, Bipolar Disorder Trial in Montpellier (Blood sample)
Unknown status
- Schizophrenia
- +2 more
- Blood sample
-
Montpellier, France(unnamed)
Dec 5, 2016
Cohort Description of Younger With AV-block
Unknown status
- Atrioventricular Block
- +2 more
- Pacemaker
-
Aarhus, DenmarkDepartment of cardiology, Research, Aarhus University Hospital,
Jan 13, 2017
Incisional Hernia Occurence Trial in Austria, Germany, Netherlands (mesh supported closure, primary closure)
Completed
- Incisional Hernia Occurence
- mesh supported closure
- primary closure
-
Vienna, Austria
- +11 more
Oct 27, 2016
Rectocele, Intussusception, Surgery Trial in Rouen (stapled transanal rectal resection, Anal compliance measure with Endoflip
Unknown status
- Rectocele
- +3 more
- stapled transanal rectal resection
- Anal compliance measure with Endoflip system
-
Rouen, FranceUH Rouen
Dec 6, 2016
Child Development Disorders, Pervasive Trial in United States (Parent Training, Psychoeducational Program)
Completed
- Child Development Disorders, Pervasive
- Parent Training
- Psychoeducational Program
-
New Haven, Connecticut
- +5 more
Apr 7, 2016
ADDICTAO: Psychological and Addictive Profile of Buerger's
Completed
- Thromboangiitis Obliterans
- Atheromatous Arteritis
-
Bordeaux, France
- +15 more
Nov 9, 2016
Fetal Alcohol Spectrum Disorders Trial in Charlottesville (CARRII, CARRII Education)
Completed
- Fetal Alcohol Spectrum Disorders
- CARRII
- CARRII Education
-
Charlottesville, VirginiaBehavioral Health and Technology Lab
Oct 24, 2016
Patients With Mild to Moderate GAD Trial (Saffron, )
Unknown status
- Patients With Mild to Moderate GAD
- Saffron
- placebo
- (no location specified)
Jun 11, 2016
Autistic Disorder Trial in Nice (Genetic test)
Completed
- Autistic Disorder
- Genetic test
-
Nice, FranceCHU de Nice
Aug 8, 2016
AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)
Completed
- AML
- +8 more
- Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jul 14, 2016
Long Term Effects of Erythrocyte Lysis
Completed
- Sickle Cell Disease
- Hemolytic Anemia
- Clinical Evaluations
- Laboratory Studies
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 24, 2016
to See Whether Negative Pressure Wound Therapy Decreases Wound Infections. Trial in Vancouver (Negative Pressure Wound Therapy,
Unknown status
- to See Whether Negative Pressure Wound Therapy Decreases Wound Infections.
- Negative Pressure Wound Therapy
- Standard Gauze Treatment
-
Vancouver, British Columbia, CanadaBC Children's Hospital
May 30, 2016
Evaluative Research in Process of Implementation ofAlternative
Unknown status
- Severe Psychiatric Disorders
- interview and observation
- (no location specified)
Aug 2, 2016